Sort
10,766 grants matching “checkpoint inhibitor”
HTLV-I Tax activates the anaphase promoting complex
$261,548Chou-Zen Giam · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2013 · CA
CELL CYCLE REGULATION DURING SPERMATOGENESIS
$261,450Jackson Laboratory · R01 · FY2003 · HD
CELL CYCLE REGULATION DURING SPERMATOGENESIS
$261,450Jackson Laboratory · R01 · FY2004 · HD
Immunomodulatory Effects of Targeting DNA Repair with Novel Temozolomide Combinations in Colorectal Cancer
$260,958Michael Cecchini · Yale University · K08 · FY2024 · CA
Immunomodulatory Effects of Targeting DNA Repair with Novel Temozolomide Combinations in Colorectal Cancer
$260,958Michael Cecchini · Yale University · K08 · FY2023 · CA
Immunomodulatory Effects of Targeting DNA Repair with Novel Temozolomide Combinations in Colorectal Cancer
$260,958Michael Cecchini · Yale University · K08 · FY2021 · CA
Immunomodulatory Effects of Targeting DNA Repair with Novel Temozolomide Combinations in Colorectal Cancer
$260,958Michael Cecchini · Yale University · K08 · FY2022 · CA
Immunomodulatory Effects of Targeting DNA Repair with Novel Temozolomide Combinations in Colorectal Cancer
$260,958Michael Cecchini · Yale University · K08 · FY2025 · CA
P3: Molecular Mechanisms Underlying Therapy Response to Radiation and Immune Checkpoint BlockadeýSUBAWARD
$260,919David Sung-Wen Yu · Cleveland Clinic Lerner Com-Cwru · U54 · FY2024 · CA
HIV 1 VPR INDUCES G2 CELL CYCLE ARREST AND APOPTOSIS
$260,873University Of California Los Angeles · R01 · FY2000 · CA
Center for Cancer Immunology and Immunotherapy (CCII)
$260,726Jun Yan · University Of Louisville · P20 · FY2023 · GM
Mechanism of the Spindle Assembly Checkpoint Control
$260,684Stanford University · R01 · FY2003 · GM
A20 Promotes Glioma Stem Cell Mediated Tumorigenesis
$260,620Anita Borton Hjelmeland · Cleveland Clinic Lerner Com-Cwru · R01 · FY2010 · CA
The use of tMUC1/CD3 bispecific antibody to control pancreatic ductal adenocarcinoma
$260,588Pinku Mukherjee · Oncotab, Inc · R41 · FY2021 · CA
Mechanism of the Spindle Assembly Checkpoint Control
$260,542Stanford University · R01 · FY2004 · GM
Overcoming the immune evasion mechanism of Merkel cell polyomavirus-associated Merkel cell carcinoma
$260,509Jianxin You · University Of Pennsylvania · R21 · FY2020 · AI
Targeting ROS enzymes in immunosuppressive myeloid cells to enhance immunotherapy
$260,435Tracy W Liu · West Virginia University · P20 · FY2024 · GM
Mechanism of the Spindle Assembly Checkpoint Control
$260,393Stanford University · R01 · FY2005 · GM
BRIT 1: Roles in Immortalization, Checkpoints and Cancer
$260,360Shiaw-Yih Lin · University Of Tx Md Anderson Can Ctr · R01 · FY2006 · CA
Project 3: Targeting Vulnerabilities in the Fibrotic Extracellular Matrix (ECM) of Lung Cancers
$260,117John D Minna · Ut Southwestern Medical Center · P50 · FY2020 · CA
Exploring the combinatorial efficacy between chemotherapy and T cell checkpoint inhibition and the role of cellular senescence
$260,099Matthew J Bott · Sloan-Kettering Inst Can Research · K08 · FY2024 · CA
Exploring the combinatorial efficacy between chemotherapy and T cell checkpoint inhibition and the role of cellular senescence
$260,099Matthew J Bott · Sloan-Kettering Inst Can Research · K08 · FY2021 · CA
Exploring the combinatorial efficacy between chemotherapy and T cell checkpoint inhibition and the role of cellular senescence
$260,099Matthew J Bott · Sloan-Kettering Inst Can Research · K08 · FY2020 · CA
Exploring the combinatorial efficacy between chemotherapy and T cell checkpoint inhibition and the role of cellular senescence
$260,099Matthew J Bott · Sloan-Kettering Inst Can Research · K08 · FY2022 · CA
Exploring the combinatorial efficacy between chemotherapy and T cell checkpoint inhibition and the role of cellular senescence
$260,099Matthew J Bott · Sloan-Kettering Inst Can Research · K08 · FY2023 · CA